Browse by Phase
Phase 1 Clinical Trials
Phase 1 trials test a new drug or treatment in a small group (20–80 people) for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects.
Total Trials
604
Recruiting Now
604
Top Conditions in Phase 1
NCT03999229 Phase 1
Recruiting
S-Nitrosylation (SNO) Therapy During Autologous Blood Transfusion
Condition
Transfusion Related Complication
Enrollment
35 pts
Location
United States
Sponsor
James Reynolds
NCT07189403 Phase 1
Recruiting
A Study of DS9051b in Participants With Advanced or Metastatic Adrenocortical Ca...
Condition
Advanced or Metastatic Adrenocortical Carcinoma
Enrollment
40 pts
Location
United States, France, United Kingdom
Sponsor
Daiichi Sankyo
NCT06709469 Phase 1
Recruiting
Phase I Clinical Trial of CART Cell Therapy for Refractory/Relapsed Acute Lympho...
Condition
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Enrollment
10 pts
Location
Spain
Sponsor
Instituto de Investigación Hos
NCT05184569 Phase 1
Recruiting
Veri-T: A Trial of Verdiperstat in Patients With svPPA Due to TDP-43 Pathology
Condition
Semantic Dementia
Enrollment
64 pts
Location
United States
Sponsor
Peter Ljubenkov, MD
NCT07265466 Phase 1
Recruiting
to Evaluate the Safety and the Pharmacokinetic and Pharmacodynamic Interactions ...
Condition
Drug Drug Interaction (DDI)
Enrollment
96 pts
Location
South Korea
Sponsor
Onconic Therapeutics Inc.
NCT07346495 Phase 1
Recruiting
A Study of Remternetug (LY3372993) in Healthy Chinese Participants
Condition
Healthy
Enrollment
24 pts
Location
China
Sponsor
Eli Lilly and Company
NCT06786234 Phase 1
Recruiting
A Phase 1 Study to Assess STP938 as a Monotherapy in Adults With High Risk Essen...
Condition
Essential Thrombocythaemia
Enrollment
20 pts
Location
France, United Kingdom
Sponsor
Step Pharma, SAS
NCT05205109 Phase 1
Recruiting
A Study to Assess the Safety, Pharmacokinetics, Pharmacodynamics, and Preliminar...
Condition
Locally Advanced or Metastatic Solid Tumors
Enrollment
98 pts
Location
Australia, China
Sponsor
Antengene Therapeutics Limited
NCT05911217 Phase 1
Recruiting
A Study to Evaluate the Efficacy and Safety of CT041 After Adjuvant Chemotherapy...
Condition
Pancreatic Cancer
Enrollment
20 pts
Location
China
Sponsor
CARsgen Therapeutics Co., Ltd.
NCT06817382 Phase 1
Recruiting
A Study to Investigate the Safety and Biodistribution of a Single Intrathecal (I...
Condition
Duchenne Muscular Dystrophy
Enrollment
12 pts
Location
United States
Sponsor
Insmed Gene Therapy LLC
NCT05836324 Phase 1
Recruiting
A Study to Evaluate the Safety of INCA33890 in Participants With Advanced or Met...
Condition
Solid Tumors
Enrollment
408 pts
Location
United States, Denmark, France
Sponsor
Incyte Corporation
NCT07007546 Phase 1
Recruiting
A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ABSK061 Mi...
Condition
Healthy
Enrollment
42 pts
Location
China
Sponsor
Abbisko Therapeutics Co, Ltd
NCT06006741 Phase 1
Recruiting
Universal CAR-T Cells Targeting Multiple Myeloma
Condition
Multiple Myeloma in Remission
Enrollment
20 pts
Location
China
Sponsor
Shenzhen Geno-Immune Medical I
NCT05452005 Phase 1
Recruiting
Fluorine-18-AlphaVBeta6-Binding Peptide Positron Emission Tomography in Metastat...
Condition
Lung Cancer
Enrollment
20 pts
Location
United States
Sponsor
University of California, Davi
NCT06736327 Phase 1
Recruiting
A Study on the Safety, Tolerability, Pharmacokinetics, and Antitumor Activity of...
Condition
Advanced Solid Tumors
Enrollment
180 pts
Location
China
Sponsor
Sichuan Kelun-Biotech Biopharm
NCT07313722 Phase 1
Recruiting
Study Evaluating Safety of BT01001 Ophthalmic Solution
Condition
Healthy
Enrollment
32 pts
Location
China
Sponsor
Beyang Therapeutics Co., Ltd.
NCT07477522 Phase 1
Recruiting
Effects of High-Fiber Diet on Gut Microbiota, Metabolism, and Immune Microenviro...
Condition
Colorectal Cancer (Diagnosis)
Enrollment
25 pts
Location
China
Sponsor
West China Hospital
NCT07157345 Phase 1
Recruiting
Testing if PDR-001 Can Safely and Effectively Remove Harmful Brain Protein in Pa...
Condition
Parkinson Disease (PD)
Enrollment
12 pts
Location
China
Sponsor
Ruijin Hospital
NCT05679895 Phase 1
Recruiting
Safety and Efficacy of OC-1 Therapy in Patients With R/R T-ALL/LL
Condition
T-cell Acute Lymphoblastic Leukemia
Enrollment
20 pts
Location
Spain
Sponsor
OneChain Immunotherapeutics
NCT05857969 Phase 1
Recruiting
Ex Vivo Drug Sensitivity Testing and Multi-Omics Profiling
Condition
Recurrent Childhood Acute Myeloid Leukemia
Enrollment
65 pts
Location
United States
Sponsor
Florida International Universi
NCT07128329 Phase 1
Recruiting
Acute Effects of Oral Nicotine Pouches
Condition
Nicotine Pouch Self-Administration
Enrollment
120 pts
Location
United States
Sponsor
Johns Hopkins University
NCT06414902 Phase 1
Recruiting
18F-AraG PET/CT as a Non-Invasive Imaging Biomarker for Chemoradiation Treatment...
Condition
Esophageal Cancer
Enrollment
60 pts
Location
United States
Sponsor
M.D. Anderson Cancer Center
NCT05504837 Phase 1
Recruiting
A Study Assessing KB407 for the Treatment of Cystic Fibrosis
Condition
Cystic Fibrosis
Enrollment
12 pts
Location
United States
Sponsor
Krystal Biotech, Inc.
NCT06801067 Phase 1
Recruiting
A Study of SER-155 to Treat Diarrhea in People on Immunotherapy
Condition
Diarrhea
Enrollment
15 pts
Location
United States
Sponsor
Memorial Sloan Kettering Cance
NCT06436742 Phase 1
Recruiting
A Phase 1b Study to Investigate Safety and Tolerability of ARGX-119 in Adult Par...
Condition
Congenital Myasthenic Syndrome
Enrollment
16 pts
Location
United States, Canada, France
Sponsor
argenx